CNA Financial’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-13,945
| Closed | -$67K | – | 78 |
|
|
2022
Q3 | $67K | Sell |
13,945
-1,570
| -10% | -$7.54K | 0.03% | 166 |
|
|
2022
Q2 | $123K | Hold |
15,515
| – | – | 0.04% | 170 |
|
|
2022
Q1 | $228K | Buy |
15,515
+270
| +2% | +$3.97K | 0.07% | 178 |
|
|
2021
Q4 | $308K | Buy |
15,245
+440
| +3% | +$8.89K | 0.08% | 179 |
|
|
2021
Q3 | $402K | Sell |
14,805
-2,220
| -13% | -$60.3K | 0.11% | 174 |
|
|
2021
Q2 | $415K | Buy |
17,025
+1,339
| +9% | +$32.6K | 0.12% | 177 |
|
|
2021
Q1 | $383K | Buy |
15,686
+4,911
| +46% | +$120K | 0.12% | 171 |
|
|
2020
Q4 | $345K | Buy |
10,775
+3,690
| +52% | +$118K | 0.11% | 179 |
|
|
2020
Q3 | $234K | Buy |
7,085
+2,220
| +46% | +$73.3K | 0.09% | 177 |
|
|
2020
Q2 | $228K | Buy |
+4,865
| New | +$228K | 0.09% | 171 |
|